showing the min to max distribution of four independent donors. Significant differences are determined using a two-tailed paired t-test between treated and mock condition for each donor. IM  NCM  NK  CD8+ T  CD4+ T  B  CCL11  CXCL1  IL8  CXCL10  CCL2  CCL3  CCL4  CXCL12  CCL5  IFNG  IL12B  IL13  IL1B  IL2  TNFA  IL4  IL6  GM-CSF  IL10  IL17  IFNA  BDNF  EGF  FGF  HGF  LIF  PDGF  PIGF  SCF Tables   Supplementary Table 1 . Viremia in NHP after challenge.
Viremia (PFUs/ml) was measured by plaque assay and viral RNA levels (copies/ml) daily for 7 days after DENV-2 challenge. For each animal identification number, the area under the curve (AUC) between day 57-63 (day 1-7 after challenge) and the peak titer during this time period were calculated with GraphPad Prism.
The lower limit of detection of the assay was <8.5x10 2 copies/ml. nd = not detected 
